Vemurafenib (VEM) in relapsed refractory multiple myeloma harboring BRAF(V600) mutations (V600m): A cohort of the histology-independent VE-basket study Meeting Abstract


Authors: Raje, N.; Chau, I.; Hyman, D. M.; Ribrag, V.; Blay, J. Y.; Tabernero, J.; Elez-Fernandez, M. E.; Wolf, J. S.; Sirzen, F.; Yee, A.; Faris, J.; Kaiser, M.; Landau, H.; Michot, J. M.; Veronese, L.; Makrutzki, M.; Lasserre, S. F.; Puzanov, I.; Baselga, J.
Abstract Title: Vemurafenib (VEM) in relapsed refractory multiple myeloma harboring BRAF(V600) mutations (V600m): A cohort of the histology-independent VE-basket study
Meeting Title: 57th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 126
Issue: 23
Meeting Dates: 2015 Dec 5-8
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2015-12-03
Language: English
ACCESSION: WOS:000368021801205
PROVIDER: wos
Notes: Meeting Abstract: 4263 -- Source: Wos